Antibiotic-free plasmids
US-9217153-B2 · Dec 22, 2015 · US
US9624520B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9624520-B2 |
| Application number | US-201414279085-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 15, 2014 |
| Priority date | Oct 24, 2008 |
| Publication date | Apr 18, 2017 |
| Grant date | Apr 18, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein is pyrroline-carboxy-lysine (PCL), a pyrrolysine analog, which is a natural, biosynthetically generated amino acid, and methods for biosynthetically generating PCL. Also disclosed herein are proteins, polypeptides and peptides that have PCL incorporated therein and methods for incorporating PCL into such proteins, polypeptides and peptides. Also disclosed herein is the site-specific derivatization of proteins, polypeptides and peptides having PCL or pyrrolysine incorporated therein. Also disclosed herein is the crosslinking of proteins, polypeptides and peptides having PCL or pyrrolysine incorporated therein.
Opening claim text (preview).
We claim: 1. A process for preparing a protein having the structure of Formula (I): R 1 -(AA) n -R 2 wherein: R 1 is H or an amino terminus modification group; R 2 is OH or a carboxy terminus modification group; n is an integer from 1 to 5000; each AA is independently selected from an amino acid residue, a pyrrolysine analogue amino acid residue having the structure of Formula (A-2) and a pyrrolysine analogue amino acid residue having the structure of Formula (B-2); and wherein at least one AA is a pyrrolysine analogue amino acid residue having the structure of Formula (A-2) or Formula (B-2); the process comprising: biosynthetically generate within a cell an amino acid of Formula (VII) or Formula (VIII): wherein the cell comprises a pylC gene, and a pylD gene, and the cell is in contact with a growth medium comprising a precursor, or wherein the cell comprises a pylB gene, a pylC gene and a pylD gene, and the cell is in contact with a growth medium comprising a precursor, incorporating the amino acid of Formula (VII) or Formula (VIII) into the protein within the cell using an orthogonal tRNA (O-tRNA) and an orthogonal aminoacyl tRNA synthetase (O—RS), wherein the O—RS aminoacylates the O-tRNA with the amino acid of Formula (VII) or Formula (VIII) and the O-tRNA recognize at least one selector codon of a mRNA in the cell, and recovering the protein. 2. The process of claim 1 , wherein the cell further comprises a pylS gene and a pylT gene and the amino acid of Formula (VII) or Formula (VIII) is incorporated into the protein within the cell by an aminoacyl tRNA synthetase and a tRNA which recognizes at least one selector codon of a mRNA in the cell, wherein the aminoacyl tRNA synthetase is a gene product of the pylS gene and the tRNA is a gene product of the pylT gene. 3. The process of claim 2 , wherein the selector codon is a TAG amber codon. 4. The process of claim 1 , wherein the precursor is D-ornithine, D-arginine, (2S)-2-amino-6-(2,5-diaminopentanamido)hexanoic acid or (2S)-2-amino-6-((R)-2,5-diaminopentanamido)hexanoic acid. 5. The process of claim 1 , wherein the cell is a prokaryotic cell or a eukaryotic cell. 6. The process of claim 5 , wherein the cell is an Escherichia coli cell, a mammalian cell, a yeast cell or an insect cell. 7. The process of claim 6 , wherein the mammalian cell is a CHO cell, a HeLa cell or a HEK293F cell and the insect cell is a sf9 cell.
with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title
Preparation of peptides or proteins (single cell protein C12N1/00) · CPC title
Sulfur atoms · CPC title
containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu · CPC title
Peptides of undefined number of amino acids; Derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.